Alignment Healthcare (NASDAQ:ALHC) Upgraded by KeyCorp to Overweight Rating

Key Points

• Alignment Healthcare (NASDAQ:ALHC) was upgraded by KeyCorp from a "sector weight" to an "overweight" rating, with a target price of $21.00, indicating a potential upside of 32.58% from its previous close.
• Despite this upgrade, other analysts such as Wall Street Zen and UBS Group have issued more cautious ratings, contributing to an overall consensus rating of "Moderate Buy" with a price target of $18.83.
• Recent insider trading includes significant sales by directors, where Joseph S. Konowiecki and Hyong Kim sold a combined total of 49,800 shares, reflecting a decrease in their ownership of the company's stock.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) was upgraded by investment analysts at KeyCorp from a "sector weight" rating to an "overweight" rating in a research report issued on Monday, MarketBeat reports. The firm presently has a $21.00 target price on the stock. KeyCorp's target price suggests a potential upside of 32.58% from the company's previous close.

ALHC has been the subject of several other reports. Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, August 10th. UBS Group raised their price objective on shares of Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Zacks Research raised shares of Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Finally, Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their target price for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, Alignment Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $18.83.

Alignment Healthcare Trading Up 0.3%

Shares of ALHC stock opened at $15.84 on Monday. The firm has a 50 day moving average price of $13.77 and a two-hundred day moving average price of $15.30. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The company has a market capitalization of $3.14 billion, a PE ratio of -56.57 and a beta of 1.16. Alignment Healthcare has a 12-month low of $8.65 and a 12-month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.14. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business's revenue for the quarter was up 49.0% compared to the same quarter last year. During the same period last year, the business posted ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts predict that Alignment Healthcare will post -0.69 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $16.00, for a total value of $400,000.00. Following the transaction, the director directly owned 1,152,049 shares of the company's stock, valued at $18,432,784. This trade represents a 2.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Hyong Kim sold 24,800 shares of Alignment Healthcare stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $16.00, for a total transaction of $396,800.00. Following the completion of the transaction, the insider directly owned 447,367 shares in the company, valued at $7,157,872. This trade represents a 5.25% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 624,153 shares of company stock valued at $9,037,301 over the last three months. 6.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. MCF Advisors LLC increased its stake in Alignment Healthcare by 87.6% in the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after acquiring an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ bought a new position in Alignment Healthcare in the first quarter valued at approximately $42,000. SBI Securities Co. Ltd. increased its stake in Alignment Healthcare by 4,868.9% in the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company's stock valued at $42,000 after acquiring an additional 2,970 shares during the last quarter. KBC Group NV bought a new position in Alignment Healthcare in the second quarter valued at approximately $44,000. Finally, Signaturefd LLC increased its stake in Alignment Healthcare by 142.6% in the second quarter. Signaturefd LLC now owns 3,768 shares of the company's stock valued at $53,000 after acquiring an additional 2,215 shares during the last quarter. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.